MarketInOut Stock Screener Log In | Sign Up

Pharmaron Beijing Co Ltd

HKSE • Healthcare • Biotechnology • Quote as of 10/30/2026
Pharmaron Beijing Co Ltd stock price and volume chart

Company Profile

IndustryBiotechnology
SectorHealthcare
ExchangeHKSE
Market Capitalization48,835 mln
Float352 mln
Earnings Date03/29/2027

EPS

1.07
Moderate

P / E

25.21
Elevated

Piotroski F-Score

6 / 9
Solid

Beneish M-Score

-2.5
Borderline

1-Year Forecast

40.08
Exceptional upside

Relative Strength

68 / 100
Outperforming

Business Description

Founded in Beijing in 2004, Pharmaron is a global drug research and development company that helps pharmaceutical clients move new medicines from early discovery through to clinical trials and manufacturing. The company supports a wide range of therapies, from traditional small-molecule drugs to more advanced biological treatments, including cell and gene therapies. It serves clients across North America, Europe, China, and the broader Asia region.

Key Fundamentals

EPS1.07
P/E25.21
ROE11.70
RPS9.72
ROIC6.82
ROA6.60
Interest Cover10.82
EBITDA, mln4,119
EV / EBITDA21.04
EV / EBIT33.69
Revenue, mln17,042
EV / Revenue5.09

Quote Details

Last 26.98
Change 0.06 (0.22%)
Open 26.92
Volume 7,753,619
Turnover 209,192,640
Average Volume 6,188,774

Financial Ratios

Pre-Tax Profit Margin14
Leverage Ratio1.77
Current Ratio1.02
Price / Book4.19
Price / Tangible Book5.92
Price / Cash Flow23.37
Price / Free Cash Flow683
Debt / Equity0.43
Price / Sales4.42
PEG Ratio1.82

Financial Strength

Altman Z-Score4.59
Piotroski F-Score 6 / 9
Beneish M-Score-2.5
Price to Intrinsic Value4.90
Price to Lynch Fair Value4.01
Price to Graham Number3.27
1-Year Target Price40.08
Shiller PE Ratio61.81

Price Performance & Relative Strength

Period Price Performance Relative Strength
1 Week -0.07% 58 / 100   
1 Month -10.25% 39 / 100   
2 Months 14.03% 85 / 100   
6 Months 25.61% 90 / 100   
1 Year 12.37% 76 / 100   



Disclaimer - Privacy Policy - Terms of Service - Cookies - FAQ - Affiliates - Blog